Transplant Survival and Transplant Living
Liver transplantation has been accepted as a life-saving treatment and standard of care for many forms of end-stage liver disease since the early 1980. Liver transplants used deceased donor livers. If a liver transplant candidate is eligible to receive from a living donor, then a family member, relative or close friend can be considered for donation. Living donor transplantation proposals and another to waiting for a deceased-donor organ to become available for people in need of an organ transplant. In addition, living-donor organ transplants. As associated with less complications than deceased-donor transplants and, overall, a longer survival of the donor organ.
Related Conference of Transplant Survival and Transplant Living
March 09-10, 2026
21th World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research
Singapore City, Singapore
June 18-19, 2026
16th International Conference on Human Genetics and Genetic Diseases
Singapore City, Singapore
June 18-19, 2026
19th International Conference on Genomics & Pharmacogenomics
Singapore City, Singapore
Transplant Survival and Transplant Living Conference Speakers
Recommended Sessions
- Cyclosporine
- Drug Delivery in Transplantation
- Heart transplant
- Immunosuppressant
- Kaposi Sarcoma in case of solid organ transplantation
- Kidney transplant
- Lung transplant
- Medicine - Surgery
- Organ Donation
- Organ Rejection
- Organ Transplantation
- Organ Transplantation Market to Ascent Exponentially
- Skin & Tissue Grafting
- Stem Cell Transplantation
- Transplant Survival and Transplant Living
- Transplantation Special legal and Ethical problems
- Trends in Organ Transplantation
Related Journals
Are you interested in
- Artificial Intelligence and Computational Biology in Regenerative Medicine - Stemgen 2026 (France)
- Biomaterials and Nanotechnology in Regenerative Medicine - Stemgen 2026 (France)
- Cancer Stem Cells and Oncology - Stemgen 2026 (France)
- Cardiovascular Regeneration - Stemgen 2026 (France)
- Clinical Trials and Translational Stem Cell Research - Stemgen 2026 (France)
- Ethical, Legal, and Social Implications in Stem Cell Research - Stemgen 2026 (France)
- Future Trends: Organoids, Bioengineering, and Next-Generation Therapies - Stemgen 2026 (France)
- Gene Editing and CRISPR Technologies - Stemgen 2026 (France)
- Induced Pluripotent Stem Cells (iPSCs) and Reprogramming - Stemgen 2026 (France)
- Mesenchymal Stem Cells (MSCs) in Therapy - Stemgen 2026 (France)
- Regenerative Dentistry and Craniofacial Applications - Stemgen 2026 (France)
- Regenerative Medicine and Tissue Engineering - Stemgen 2026 (France)
- Stem Cell Banking and Cryopreservation - Stemgen 2026 (France)
- Stem Cell Biology and Cellular Mechanisms - Stemgen 2026 (France)
- Stem Cells in Neurological and Neurodegenerative Disorders - Stemgen 2026 (France)